| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/21/2013 | US8444999 Mutated Salmonella typhi strain and use thereof in a vaccine |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444987 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8444965 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2670933C Multi-channel electroporation system |
| 05/21/2013 | CA2601209C Bovine cast gene snp and meat tenderness |
| 05/21/2013 | CA2597573C Method for the isolation of nucleic acids |
| 05/21/2013 | CA2580189C Sirna-mediated gene silencing of alpha synuclein |
| 05/21/2013 | CA2569988C Phage microarray profiling of the humoral response to disease |
| 05/21/2013 | CA2537065C Method for producing rose with altered petal colors |
| 05/21/2013 | CA2526806C Proteases |
| 05/21/2013 | CA2522614C Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 05/21/2013 | CA2509227C Elevation of oil levels in brassica plants |
| 05/21/2013 | CA2468179C Method for producing l-amino acids using bacteria belonging to the genus escherichia |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2454147C Inhibitor of dna methylation |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2403344C Effective nuclear reprogramming in mammals |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2363662C Sequences and methods for detection of hiv-1 |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/21/2013 | CA2279329C Protein fragment complementation assays to detect biomolecular interactions |
| 05/16/2013 | WO2013071295A2 Transcript optimized expression enhancement for high-level production of proteins and protein domains |
| 05/16/2013 | WO2013071224A1 Method for detecting a target analyte using a self-cleaving synthetic molecule |
| 05/16/2013 | WO2013071172A1 Production of acetyl-coenzyme a derived isoprenoids |
| 05/16/2013 | WO2013071161A1 Compounds for the modulation of beta-catenin expression and uses thereof |
| 05/16/2013 | WO2013071154A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
| 05/16/2013 | WO2013071079A1 Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics |
| 05/16/2013 | WO2013071047A1 Compositions and methods for in vitro transcription of rna |
| 05/16/2013 | WO2013071022A1 Antisense oligonucleotide modulators of serotonin receptor 2c and uses thereof |
| 05/16/2013 | WO2013070949A1 Consolidated bioprocess for biofuel and chemical production from lignocellulosic biomass |
| 05/16/2013 | WO2013070843A1 Genetically modified cells and methods for making activated sugar-nucleotides |
| 05/16/2013 | WO2013070821A1 Methods and compositions for treating diseases, disorders or injury of the nervous system |
| 05/16/2013 | WO2013070786A1 Modulation of tmprss6 expression |
| 05/16/2013 | WO2013070776A1 Neutralizing gp41 antibodies and their use |
| 05/16/2013 | WO2013070763A1 Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy |
| 05/16/2013 | WO2013070563A1 Treatment of autoimmune and inflammatory disorders by inhibition of blimp-1 |
| 05/16/2013 | WO2013070167A1 The use of a synthetic dna-antibody complex as external reference for chromatin immunoprecipitation |
| 05/16/2013 | WO2013070060A1 One step multiplex system for the detection of salmonella spp., s. typhi and s. paratyphi a with an internal control |
| 05/16/2013 | WO2013070056A1 Production of a low-molecular-weight recombinant metalloproteinaise (50 kda) oftrichomonas vaginalis and identification of the gene that codes for said low-molecular-weight metalloproteinase (50 kda) that is expressed differentially in the presence of zn+2 |
| 05/16/2013 | WO2013070055A1 Production of anti tvmp50r polyclonal antibodies that can be used in the diagnosis of trichomonas vaginalis in men |
| 05/16/2013 | WO2013069773A1 Base-supporting labeling method, base sequence information acquisition method, and base-supporting labeled single-stranded nucleic acid |
| 05/16/2013 | WO2013069741A1 Antibody specific to profilaggrin c-terminal domain, and use thereof |
| 05/16/2013 | WO2013069732A1 Magnetic nanoparticles |
| 05/16/2013 | WO2013069645A1 Method for measuring ethanolamine phosphate |
| 05/16/2013 | WO2013069634A1 Method for producing target substance by fermentation |
| 05/16/2013 | WO2013069611A1 Rna having immunomodulating activity |
| 05/16/2013 | WO2013069495A1 Method for predicting risk of porencephaly or cerebral hemorrhage |
| 05/16/2013 | WO2013068847A2 Compositions and methods for treatment of cytomegalovirus |
| 05/16/2013 | WO2013068845A2 Endonuclease for genome editing |
| 05/16/2013 | WO2013068836A1 A ddr1 antagonist or an inhibitor of ddr1 gene expression for use in the prevention or treatment of crescentic glomerulonephritis |
| 05/16/2013 | WO2013068692A1 Expression cassette for modifying the genome of bacteria and for modifying a vector in a bacterial strain |
| 05/16/2013 | WO2013068600A1 Medicament for the treatment of cardiac disease |
| 05/16/2013 | WO2013068441A1 Compounds for the modulation of smn2 splicing |
| 05/16/2013 | WO2013068413A1 Rod cell-specific promoter |
| 05/16/2013 | WO2013068348A1 Lna oligomers for improvement in hepatic function |
| 05/16/2013 | WO2013068309A1 Methods for production of archeae protease in yeast |
| 05/16/2013 | WO2013068107A1 Lysis method and lysis composition |
| 05/16/2013 | WO2013068096A1 Inducible expression cassette, and uses thereof |
| 05/16/2013 | WO2013067964A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 05/16/2013 | WO2013067928A1 Construct for regulating fertility of plant pollens and usage thereof |
| 05/16/2013 | WO2013067901A1 Specific expression promoter of late development stage of plant pollens and use thereof |
| 05/16/2013 | WO2013067873A1 Anti-influenza virus nucleic acid, peptide nucleic acid and formulation thereof |
| 05/16/2013 | WO2013067719A1 Bioengineering strain for producing new microbial fungicide and use thereof |
| 05/16/2013 | WO2013067652A1 Facilitator-dna combination vaccine |
| 05/16/2013 | WO2013043878A3 Alternative splicing variants of genes associated with prostate cancer risk and survival |
| 05/16/2013 | WO2013043012A3 Novel use of leucyl trna synthetase |
| 05/16/2013 | WO2013040060A3 Nucleic acids for multiplex detection of hepatitis c virus |
| 05/16/2013 | WO2013039990A9 Methods and compositions for weed control |
| 05/16/2013 | WO2013022757A3 Banana mads-box genes for banana ripening control |
| 05/16/2013 | WO2013009084A3 Composition for simultaneously detecting mycobacterium tuberculosis and nontuberculous mycobacteria by means of real-time multiplex polymerase chain reaction comprising nested hybridization pna probe system having parallel binding structure, and method for detection using same |
| 05/16/2013 | WO2013009070A9 Nested hybridization pna probe system having parallel binding structure |
| 05/16/2013 | WO2013003291A3 Chemically modified sophorolipids and uses thereof |
| 05/16/2013 | WO2012173994A3 Phase changing formulations of nucleic acid payloads |
| 05/16/2013 | WO2012170768A3 Hybrid tomatoes and methods of making hybrid tomatoes |
| 05/16/2013 | WO2012135696A3 Methods and compositions for the diagnosis, classification, and treatment of cancer |
| 05/16/2013 | WO2012065166A3 Dominant negative mutant kip-related proteins (krp) in zea mays and methods of their use |
| 05/16/2013 | US20130125268 Plant haemoglobin |
| 05/16/2013 | US20130125266 Method for gene introduction into hordeum plant using agrobacterium, and method for production of transformed plant of hordeum plant |
| 05/16/2013 | US20130125265 Agrobacterium-mediated method for producing transformed plant |
| 05/16/2013 | US20130125264 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 05/16/2013 | US20130125263 Transgenic plants having increased biomass |
| 05/16/2013 | US20130125262 Plants having enhanced yield-related traits and a method for making the same |
| 05/16/2013 | US20130125261 Dna sequence containing the promoter region and regulatorelements of the mec1 gene, expressed in cassava roots, for use in genetic improvement programs |
| 05/16/2013 | US20130125260 Bioassay for gene silencing constructs |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130125258 Isolated polynucleotides and polypeptides for increasing plant yield and/or agricultural characteristics |
| 05/16/2013 | US20130125257 Corn with increased yield and nitrogen utilization efficiency |
| 05/16/2013 | US20130125256 Nitrate transport components |
| 05/16/2013 | US20130125255 Transgenic Plants With Increased Stress Tolerance and Yield |
| 05/16/2013 | US20130125254 Citrus tristeza virus based vectors for foreign gene/s expression |
| 05/16/2013 | US20130123566 Radiation sensitization agents for prostate cancer |
| 05/16/2013 | US20130123543 Polyacetylenic Compounds with Anti-Fungal Activity Derived from the Bacterium Collimonas and Methods for the Preparation and Identification Thereof |
| 05/16/2013 | US20130123484 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/16/2013 | US20130123483 Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein |